ArticleDiscover imaging2025
Adapting segment anything model for hematoma segmentation in traumatic brain injury.
Article in Discover imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bacopa monniera: A Promising Phytotherapeutic Approach in Management of Diabetes-Related Complications.Phytotherapy research : PTR · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hematoma segmentation in traumatic brain injury (TBI) is critical for accurate diagnosis and effective treatment planning. In this study, we evaluate various automated segmentation models, including stat-of-the-art architecture as benchmarks, and compare their performance with our proposed SAM-Adapter method for segmenting hematomas in brain CT scans. By incorporating the adapter into the vanilla SAM model, we address the challenges in medical imaging, which has very limited annotated datasets, enhancing model performance efficiency. We also find that domain-specific pre-processing, such as contrast adjustment, reduces the need for extensive pretraining, making the model more streamlined. And the model performance benefited with optimization and hyperparameter tuning. Our results demonstrate that the SAM-Adapter model achieved strong performance and reliability in identifying hematomas with Dice (72.34%), IoU (59.78%), 95% HD (5.57), sensitivity (75.39%) and specificity (99.73%). Inter-observer variability was assessed, revealing that the model's performance Dice (67.20%) was closely aligned with human expert agreement Dice (63.79%), suggesting its potential clinical utility. The external validation on the HemSeg-200 dataset, which contains 222 scans, demonstrates the robustness of our approach across diverse cases. These advancements in automatic segmentation hold promise for improving the accuracy and efficiency of TBI diagnosis, supporting clinical decision-making, and enhancing patient outcomes. Supplementary Information: The online version contains supplementary material available at 10.1007/s44352-025-00011-4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.